help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 24, 2006
Endocrinology, doi:10.1210/en.2006-0503
A more recent version of this article appeared on December 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
147/12/5611    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lu, C.
Right arrow Articles by Menon, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, C.
Right arrow Articles by Menon, R. K.

Submitted on April 19, 2006
Accepted on August 14, 2006

Insulin-like peptide 6 (Insl6): Characterization of secretory status and post-translational modifications

Chunxia Lu, William H. Walker, Jinhong Sun, Ora A. Weisz, Robert B. Gibbs, Selma F. Witchel, Mark A. Sperling, and Ram K. Menon*

Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109, USA; Departments of Cell Biology and Physiology, Pediatrics, Medicine, University of Pittsburgh School of Medicine, Pittsburgh 15213, USA, and Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh 15260, USA

* To whom correspondence should be addressed. E-mail: rammenon{at}umich.edu.

Insulin-like peptide 6 (Insl6) is a member of the insulin/relaxin superfamily with unknown biological function(s). In the current report, we establish that meiotic and post-meiotic germ cells of the testis are the principal sites of expression of Insl6. Analysis of stably or transiently transfected cells revealed that Insl6 is a secreted protein localized to the endoplasmic reticulum and Golgi. Secretion could be detected in both CHO and GC2 germ cells and was sensitive to brefeldin A treatment. In cell lysates, the predominant Insl6 band was approximately 28 kDa in size. In contrast, the predominant Insl6 species in the supernatant was 8 kDa in size, suggesting post-translational processing of the precursor protein. Ectopically expressed Insl6 is processed and secreted in furin deficient LoVo cells and in CHO cells treated with a furin inhibitor, although the size-profile of the secreted protein is altered suggesting that Insl6 is a substrate for furin action. Furthermore, mutation of a putative furin cleavage site in the Insl6 peptide resulted in aberrant processing of the Insl6 peptide. Additional investigations of the structure of Insl6 protein provided evidence for post-translational modifications of Insl6 including the presence of disulfide bonds, glycosylation, and ubiquitination. On the basis of the demonstrated secretory status of Insl6, we speculate that the physical proximity of the germ cell to the Sertoli cell renders the Sertoli cell a likely candidate for Insl6 action.


Key words: germ cell • secretion • furin • ubiquination • glycosylation







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society